TLDR: Jeremy Elser, Head of Science Operations at Palantir Technologies, is set to deliver the keynote address at the 2025 Advanced Lateral Flow Conference (ALFC). His presentation, titled ‘From Battlefield to Benchside: How Strategic AI is Reshaping Science Ops,’ will explore how AI applications from high-stakes environments like defense and global health can revolutionize diagnostics development, emphasizing improved decision-making, data pipelines, and scalable infrastructure.
LA JOLLA, CA – DCN Dx has announced that Jeremy Elser, Ph.D., Head of Science Operations at Palantir Technologies, will be the keynote speaker at the highly anticipated 2025 Advanced Lateral Flow Conference (ALFC). The conference is scheduled to take place from October 14–15, 2025, at the Hilton La Jolla Torrey Pines.
Dr. Elser’s keynote address, titled ‘From Battlefield to Benchside: How Strategic AI is Reshaping Science Ops,’ promises to offer profound insights into the transformative potential of artificial intelligence in the field of diagnostics. His presentation will delve into how AI deployments, traditionally seen in high-stakes environments such as defense, global health initiatives, and complex supply chain command centers, are now poised to inform and accelerate a new era of diagnostics development.
Drawing upon Palantir’s extensive experience in these demanding sectors, Dr. Elser will outline a strategic approach for diagnostics teams. He aims to demonstrate how applying systems-level thinking can lead to the creation of smarter, more resilient development programs. The focus will extend beyond mere automation, emphasizing the critical role of AI in enabling better decision-making, establishing stronger data pipelines, and building scalable infrastructure within the diagnostics industry.
Commenting on the upcoming address, Dr. Elser stated, “As generative and strategic AI tools become more accessible, diagnostics teams need to move past the buzzwords and understand where these systems can actually improve scientific and operational performance. This talk is about what we’ve learned in the field and how that translates to regulated, science-driven teams working under pressure.”
Attendees can get a preview of Dr. Elser’s perspective by listening to the latest episode of DCN Dx’s Expert Insights podcast, titled ‘Generative AI in Diagnostics: What’s Real, What’s Hype,’ available on Spotify and the DCN Dx website.
Also Read:
- Reuters Events to Host Momentum AI London 2025: Driving Enterprise Transformation with Generative and Agentic AI
- RAISE Summit 2025: Enterprise AI Infrastructure Takes Center Stage in Paris
The ALFC serves as a crucial gathering for the international lateral flow and rapid diagnostics community. Hosted by DCN Dx, a leading IVD CDMO and CRO, the conference provides a platform for exchanging insights, examining cutting-edge technologies, and fostering connections between technical and commercial stakeholders. The theme for this year’s conference, ‘Catalyzing Growth: Tech Advancements, Funding, and Regulatory Roadmaps in LFA,’ underscores the key dynamics shaping the lateral flow assay field in 2025. For more information or to register, interested parties can visit alfc2025.com.
